Ten years ago, Sajith Wickramasekara dropped out of the Computer Science program at MIT to build something new: a software company that helps life science researchers better organize their lab work.
Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...
Sajith Wickramasekara was just 24 when he made the cut for the Forbes 30 Under 30 list for his biotech R&D startup, Benchling. Today, Wickramasekara joins the ranks of unicorn founders as Benchling ...
Benchling announced a new collaboration with Merck, known as MSD outside of the United States and Canada, to implement a software framework that helps bring Merck's pre-clinical and clinical ...
SAN FRANCISCO and BOSTON, May 11, 2026 /PRNewswire/ -- Benchling announced Benchling Biologics, an end-to-end platform for antibody R&D, today at the PEGS Boston Summit. Scientists can configure any ...
Benchling’s unicorn status didn’t come overnight. Some 10 years after its founding, the company is worth more than $6 billion, and the founder sees the company going public in the future. The ...
SAN FRANCISCO, May 20, 2026 /PRNewswire/ -- Benchling and Baseten today announced Benchling Inference, giving biotech customers scalable, cost-effective GPU capacity to train and run scientific models ...
Life sciences-focused cloud startup Benchling has seen its business soar over the last few years due to the pandemic, and a renewed interest in biotech among investors. Now, just as it hits a ...
Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...
Last year, Benchling raised $200 million through a series E round to help expand its digital platform followed by a $100 million series F just over six months later ...
Benchling is a next-gen laboratory informatics platform that is helping life science companies manage increasingly complex data workflows. GEN Edge talks to CEO/co-founder Saji Wickramasekara and ...
Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run "Most R&D systems can't represent the antibody formats teams are actually working with," said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results